Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. De la Garza, R; Madras, BK
   [H-3]PNU-101958, a D-4 dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain
   SYNAPSE
   
   R. De la Garza e B.K. Madras, "[H-3]PNU-101958, a D-4 dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain", SYNAPSE, 37(3), 2000, pp. 232-244
2. Kulkarni, SK; Ninan, I
   Dopamine D-4 receptors and development of newer antipsychotic drugs
   FUNDAMENTAL & CLINICAL PHARMACOLOGY
   
   S.K. Kulkarni e I. Ninan, "Dopamine D-4 receptors and development of newer antipsychotic drugs", FUN CL PHAR, 14(6), 2000, pp. 529-539
3. Zhang, K; Tarazi, FI; Baldessarini, RJ
   Dopamine D-4 receptors in rat forebrain: Unchanged with amphetamine-induced behavioral sensitization
   NEUROSCIENCE
   
   K. Zhang et al., "Dopamine D-4 receptors in rat forebrain: Unchanged with amphetamine-induced behavioral sensitization", NEUROSCIENC, 97(2), 2000, pp. 211-213
4. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Adhumeau, A; Brocco, M; Nicolas, JP; Boutin, JA; Despaux, N; Peglion, JL
   S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile
   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
   
   M.J. Millan et al., "S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile", J PHARM EXP, 292(1), 2000, pp. 38-53
5. Gurevich, EV; Joyce, JN
   Dopamine D-3 receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat
   JOURNAL OF COMPARATIVE NEUROLOGY
   
   E.V. Gurevich e J.N. Joyce, "Dopamine D-3 receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat", J COMP NEUR, 420(1), 2000, pp. 35-51
6. Hoare, SRJ; Coldwell, MC; Armstrong, D; Strange, PG
   Regulation of human D-1, D-2(long), D-2(short), D-3 and D-4 dopamine receptors by amiloride and amiloride analogues
   BRITISH JOURNAL OF PHARMACOLOGY
   
   S.R.J. Hoare et al., "Regulation of human D-1, D-2(long), D-2(short), D-3 and D-4 dopamine receptors by amiloride and amiloride analogues", BR J PHARM, 130(5), 2000, pp. 1045-1059
7. Ishiwata, K; Senda, M
   In vivo binding of [C-11]nemonapride to sigma receptors in the cortex and cerebellum
   NUCLEAR MEDICINE AND BIOLOGY
   
   K. Ishiwata e M. Senda, "In vivo binding of [C-11]nemonapride to sigma receptors in the cortex and cerebellum", NUCL MED BI, 26(6), 1999, pp. 627-631
8. Kawashima, N; Nakamura, A; Okuyama, S; Chaki, S; Tomisawa, K
   Effects of NRA0045, NRA0160, and NRA0215 on regional Fos-like immunoreactivity in the rat brain
   GENERAL PHARMACOLOGY
   
   N. Kawashima et al., "Effects of NRA0045, NRA0160, and NRA0215 on regional Fos-like immunoreactivity in the rat brain", GEN PHARM, 32(6), 1999, pp. 637-646
9. Kawashima, N; Okuyama, S; Omura, T; Chaki, S; Tomisawa, K
   Effects of selective dopamine D-4 receptor blockers, NRA0160 and L-745,870, on A9 and A10 dopamine neurons in rats
   LIFE SCIENCES
   
   N. Kawashima et al., "Effects of selective dopamine D-4 receptor blockers, NRA0160 and L-745,870, on A9 and A10 dopamine neurons in rats", LIFE SCI, 65(24), 1999, pp. 2561-2571
10. Okuyama, Y; Ishiguro, H; Toru, M; Arinami, T
    A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    Y. Okuyama et al., "A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia", BIOC BIOP R, 258(2), 1999, pp. 292-295
11. BOY C; KLIMKE A; HOLSCHBACH M; HERZOG H; MUHLENSIEPEN H; KOPS ER; SONNENBERG F; GAEBEL W; STOCKLIN G; MARKSTEIN R; MULLERGARTNER HW
    IMAGING DOPAMINE D-4 RECEPTORS IN THE LIVING PRIMATE BRAIN - A POSITRON-EMISSION-TOMOGRAPHY STUDY USING THE NOVEL D-1 D-4 ANTAGONIST [C-11]SDZ-GLC-756/
    Synapse
    
    C. Boy et al., "IMAGING DOPAMINE D-4 RECEPTORS IN THE LIVING PRIMATE BRAIN - A POSITRON-EMISSION-TOMOGRAPHY STUDY USING THE NOVEL D-1 D-4 ANTAGONIST [C-11]SDZ-GLC-756/", Synapse, 30(4), 1998, pp. 341-350
12. PILLAI G; BROWN NA; MCALLISTER G; MILLIGAN G; SEABROOK GR
    HUMAN D-2 AND D-4 DOPAMINE-RECEPTORS COUPLE THROUGH BETA-GAMMA G-PROTEIN SUBUNITS TO INWARDLY RECTIFYING K- SELECTIVE ANTAGONISM BY L-741,626 AND L-745,870 RESPECTIVELY( CHANNELS (GIRK1) IN A XENOPUS OOCYTE EXPRESSION SYSTEM )
    Neuropharmacology
    
    G. Pillai et al., "HUMAN D-2 AND D-4 DOPAMINE-RECEPTORS COUPLE THROUGH BETA-GAMMA G-PROTEIN SUBUNITS TO INWARDLY RECTIFYING K- SELECTIVE ANTAGONISM BY L-741,626 AND L-745,870 RESPECTIVELY( CHANNELS (GIRK1) IN A XENOPUS OOCYTE EXPRESSION SYSTEM )", Neuropharmacology, 37(8), 1998, pp. 983-987
13. JOYCE JN; MEADORWOODRUFF JH
    LINKING THE FAMILY OF D-2 RECEPTORS TO NEURONAL CIRCUITS IN HUMAN BRAIN - INSIGHTS INTO SCHIZOPHRENIA
    Neuropsychopharmacology
    
    J.N. Joyce e J.H. Meadorwoodruff, "LINKING THE FAMILY OF D-2 RECEPTORS TO NEURONAL CIRCUITS IN HUMAN BRAIN - INSIGHTS INTO SCHIZOPHRENIA", Neuropsychopharmacology, 16(6), 1997, pp. 375-384
14. SEEMAN P; CORBETT R; VANTOL HHM
    ATYPICAL NEUROLEPTICS HAVE LOW-AFFINITY FOR DOPAMINE D-2 RECEPTORS ORARE SELECTIVE FOR D-4 RECEPTORS
    Neuropsychopharmacology
    
    P. Seeman et al., "ATYPICAL NEUROLEPTICS HAVE LOW-AFFINITY FOR DOPAMINE D-2 RECEPTORS ORARE SELECTIVE FOR D-4 RECEPTORS", Neuropsychopharmacology, 16(2), 1997, pp. 93-110
15. WONG DF; PEARLSON GD; TUNE LE; YOUNG LT; MELTZER CC; DANNALS RF; RAVERT HT; REITH J; KUHAR MJ; GJEDDE A
    QUANTIFICATION OF NEURORECEPTORS IN THE LIVING HUMAN BRAIN .4. EFFECTOF AGING AND ELEVATIONS OF D-2-LIKE RECEPTORS IN SCHIZOPHRENIA AND BIPOLAR ILLNESS
    Journal of cerebral blood flow and metabolism
    
    D.F. Wong et al., "QUANTIFICATION OF NEURORECEPTORS IN THE LIVING HUMAN BRAIN .4. EFFECTOF AGING AND ELEVATIONS OF D-2-LIKE RECEPTORS IN SCHIZOPHRENIA AND BIPOLAR ILLNESS", Journal of cerebral blood flow and metabolism, 17(3), 1997, pp. 331-342
16. DEAN B; PAVEY G; OPESKIN K
    [H-3] RACLOPRIDE BINDING TO BRAIN-TISSUE FROM SUBJECTS WITH SCHIZOPHRENIA - METHODOLOGICAL ASPECTS
    Neuropharmacology
    
    B. Dean et al., "[H-3] RACLOPRIDE BINDING TO BRAIN-TISSUE FROM SUBJECTS WITH SCHIZOPHRENIA - METHODOLOGICAL ASPECTS", Neuropharmacology, 36(6), 1997, pp. 779-786
17. HELMESTE DM; TANG SW; LI M; FANG H
    MULTIPLE [H-3] NEMONAPRIDE BINDING-SITES IN CALF BRAIN
    Naunyn-Schmiedeberg's archives of pharmacology
    
    D.M. Helmeste et al., "MULTIPLE [H-3] NEMONAPRIDE BINDING-SITES IN CALF BRAIN", Naunyn-Schmiedeberg's archives of pharmacology, 356(1), 1997, pp. 17-21
18. MARZELLA PL; HILL C; KEKS N; SINGH R; COPOLOV D
    THE BINDING OF BOTH [H-3] NEMONAPRIDE AND [H-3] RACLOPRIDE IS INCREASED IN SCHIZOPHRENIA
    Biological psychiatry
    
    P.L. Marzella et al., "THE BINDING OF BOTH [H-3] NEMONAPRIDE AND [H-3] RACLOPRIDE IS INCREASED IN SCHIZOPHRENIA", Biological psychiatry, 42(8), 1997, pp. 648-654
19. ROBERTS DA; BALDERSON D; PICKERINGBROWN SM; DEAKIN JFW; OWEN F
    THE RELATIVE ABUNDANCE OF DOPAMINE D-4 RECEPTOR MESSENGER-RNA IN POST-MORTEM BRAINS OF SCHIZOPHRENICS
    Schizophrenia research
    
    D.A. Roberts et al., "THE RELATIVE ABUNDANCE OF DOPAMINE D-4 RECEPTOR MESSENGER-RNA IN POST-MORTEM BRAINS OF SCHIZOPHRENICS", Schizophrenia research, 20(1-2), 1996, pp. 171-174
20. MULCRONE J; KERWIN RW
    NO DIFFERENCE IN THE EXPRESSION OF THE D4 GENE IN POSTMORTEM FRONTAL-CORTEX FROM CONTROLS AND SCHIZOPHRENICS
    Neuroscience letters
    
    J. Mulcrone e R.W. Kerwin, "NO DIFFERENCE IN THE EXPRESSION OF THE D4 GENE IN POSTMORTEM FRONTAL-CORTEX FROM CONTROLS AND SCHIZOPHRENICS", Neuroscience letters, 219(3), 1996, pp. 163-166
21. INOUE T; TSUCHIYA K; KOYAMA T
    EFFECTS OF TYPICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS ON FREEZING BEHAVIOR INDUCED BY CONDITIONED FEAR
    Pharmacology, biochemistry and behavior
    
    T. Inoue et al., "EFFECTS OF TYPICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS ON FREEZING BEHAVIOR INDUCED BY CONDITIONED FEAR", Pharmacology, biochemistry and behavior, 55(2), 1996, pp. 195-201
22. HARRISON PJ
    ADVANCES IN POST-MORTEM MOLECULAR NEUROCHEMISTRY AND NEUROPATHOLOGY -EXAMPLES FROM SCHIZOPHRENIA RESEARCH
    British Medical Bulletin
    
    P.J. Harrison, "ADVANCES IN POST-MORTEM MOLECULAR NEUROCHEMISTRY AND NEUROPATHOLOGY -EXAMPLES FROM SCHIZOPHRENIA RESEARCH", British Medical Bulletin, 52(3), 1996, pp. 527-538
23. LAJINESS ME; CHIO CL; HUFF RM
    SIGNALING MECHANISMS OF D-2, D-3, AND D-4 DOPAMINE-RECEPTORS DETERMINED IN TRANSFECTED CELL-LINES
    Clinical neuropharmacology
    
    M.E. Lajiness et al., "SIGNALING MECHANISMS OF D-2, D-3, AND D-4 DOPAMINE-RECEPTORS DETERMINED IN TRANSFECTED CELL-LINES", Clinical neuropharmacology, 18, 1995, pp. 25-33
24. LAHTI RA; EVANS DL; STRATMAN NC; FIGUR LM
    DOPAMINE-D(4) VERSUS DOPAMINE D(2) RECEPTOR SELECTIVITY OF DOPAMINE RECEPTOR ANTAGONISTS - POSSIBLE THERAPEUTIC IMPLICATIONS
    European journal of pharmacology
    
    R.A. Lahti et al., "DOPAMINE-D(4) VERSUS DOPAMINE D(2) RECEPTOR SELECTIVITY OF DOPAMINE RECEPTOR ANTAGONISTS - POSSIBLE THERAPEUTIC IMPLICATIONS", European journal of pharmacology, 236(3), 1993, pp. 483-486